← Back to Search

Electrical Stimulation + Occupational Therapy for Stroke Recovery

N/A
Waitlist Available
Led By Jayme Knutson, PhD
Research Sponsored by MetroHealth Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Skin intact on the hemiparetic arm
Full voluntary opening/closing of the contralateral (less affected) hand
Must not have
Diagnosis (apart from stroke) that substantially affects paretic arm and hand function
Severe shoulder or hand pain
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0 to 12 weeks, 0 to 36 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing three different therapies to see which is better at helping people recover hand function after a stroke.

Who is the study for?
This trial is for adults who've had their first stroke 6-24 months ago, leading to hand weakness but can still open their other hand fully. They should be able to follow instructions and have no severe pain when using a finger stimulator. Excluded are those with other neurological issues, uncontrolled seizures, certain heart conditions, pregnancy, or visual/hearing impairments that would affect participation.
What is being tested?
The study compares three therapies aimed at improving hand function after a stroke: an electrical stimulator designed to help move fingers and thumb; occupational therapy; and possibly a combination of both. It seeks to find out which method might be most effective in aiding recovery.
What are the potential side effects?
Potential side effects may include discomfort or skin irritation from the electrical stimulator's use on the arm. Occupational therapy generally has minimal risks but could cause fatigue or muscle soreness due to repetitive exercises.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
The skin on my weaker arm is not broken or damaged.
Select...
I can fully open and close my less affected hand.
Select...
My hand mobility score is between 1 and 11 on a specific test.
Select...
I can move my shoulder and elbow well enough to use my hand for table-top tasks.
Select...
Stimulating my weak hand's muscles can open it without pain.
Select...
My arm is weak but I can move my fingers partially.
Select...
I can understand and follow three-step instructions.
Select...
I can remember at least 2 out of 3 items after half an hour.
Select...
I am not currently undergoing occupational therapy.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a condition that significantly impacts the function of my affected arm and hand, not caused by a stroke.
Select...
I have severe pain in my shoulder or hand.
Select...
I have had serious heart rhythm problems that affected my blood pressure.
Select...
I have a neurological condition like MS, Parkinson's, or a spinal cord injury.
Select...
I cannot feel my forearm or hand.
Select...
I have had a stroke in the brainstem.
Select...
I have seizures that are not controlled by medication.
Select...
I cannot move my wrist or fingers on one side without help.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0 to 12 weeks, 0 to 36 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0 to 12 weeks, 0 to 36 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Box and Blocks Test (BBT) change
Secondary study objectives
Stroke Upper Limb Capacity Scale (SULCS) change

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: CCFESExperimental Treatment2 Interventions
Contralaterally Controlled Functional Electrical Stimulation (CCFES) uses an electrical stimulator and surface electrodes placed over the paretic finger and thumb extensors to deliver stimulation with an intensity that is proportional to the degree of opening of the contralateral unimpaired hand wearing an instrumented glove. Thus, volitional opening of the nonparetic hand produces stimulated opening of the paretic hand. During the lab visits, participants in the CCFES group will use CCFES to assist hand opening during occupational therapy task practice. During their home sessions, participants in the CCFES group will use CCFES to perform hand opening exercise.
Group II: cNMESActive Control2 Interventions
Cyclic Neuromuscular Electrical Stimulation (cNMES) uses an electrical stimulator and surface electrodes over the paretic finger and thumb extensors to deliver electrical stimulation to open the weak hand. The stimulation automatically turns on and off causing the weak hand to open repetitively for several seconds at a time. During the lab visits, participants in the cNMES group will receive occupational therapy task practice. During their home sessions, participants in the cNMES group will use cNMES to perform hand opening exercise.
Group III: Task Oriented TherapyActive Control1 Intervention
Task Oriented Therapy (TOT) focuses on practicing using the weak hand to practice activities of daily living tasks. During the clinic visits, participants in the TOT group will receive occupational therapy task practice. During their home sessions, participants in the TOT group will practice using their hand to complete a list of tasks given to them by the therapist to ensure that the participant receives a high dose of task practice.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Electrical Stimulator
2013
N/A
~70
Occupational Therapy
2011
Completed Phase 3
~1200

Find a Location

Who is running the clinical trial?

MetroHealth Medical CenterLead Sponsor
118 Previous Clinical Trials
21,644 Total Patients Enrolled
16 Trials studying Stroke
827 Patients Enrolled for Stroke
Kessler FoundationOTHER
183 Previous Clinical Trials
11,041 Total Patients Enrolled
27 Trials studying Stroke
2,360 Patients Enrolled for Stroke
National Institutes of Health (NIH)NIH
2,826 Previous Clinical Trials
8,169,494 Total Patients Enrolled
44 Trials studying Stroke
8,379 Patients Enrolled for Stroke
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,061 Previous Clinical Trials
2,745,016 Total Patients Enrolled
85 Trials studying Stroke
5,676 Patients Enrolled for Stroke
The Cleveland ClinicOTHER
1,056 Previous Clinical Trials
1,371,485 Total Patients Enrolled
15 Trials studying Stroke
1,668 Patients Enrolled for Stroke
Johns Hopkins UniversityOTHER
2,332 Previous Clinical Trials
14,874,618 Total Patients Enrolled
40 Trials studying Stroke
33,188 Patients Enrolled for Stroke
Emory UniversityOTHER
1,704 Previous Clinical Trials
2,607,172 Total Patients Enrolled
31 Trials studying Stroke
350,115 Patients Enrolled for Stroke
Jayme Knutson, PhDPrincipal Investigator - MetroHealth Medical Center
MetroHealth Medical Center

Media Library

Occupational Therapy Clinical Trial Eligibility Overview. Trial Name: NCT03574623 — N/A
Stroke Research Study Groups: cNMES, Task Oriented Therapy, CCFES
Stroke Clinical Trial 2023: Occupational Therapy Highlights & Side Effects. Trial Name: NCT03574623 — N/A
Occupational Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT03574623 — N/A
~2 spots leftby Jan 2025